Notice of Results & Retail Investor Presentation

Summary by AI ^BETAClose X

Feedback plc will announce its interim results for the half year ended 30 November 2025 on Tuesday 17 February 2026, and management will host an investor presentation and Q&A session at 16:00 on the same day. Investors can register for this event via the Investor Meet Company platform.

Disclaimer*

Feedback PLC

02 February 2026

Feedback plc

Notice of Interim Results & Retail Investor Presentation

Feedback plc (AIM: FDBK, "Feedback" or the "Company"), the clinical infrastructure specialist, expects to announce results for the half year ended 30 November 2025 on Tuesday 17 February 2026.

Investor Presentation: 16:00, Tuesday 17 February

Management will be providing a presentation and hosting an investor Q&A session on the Company's results and future prospects on Tuesday 17 February at 16:00. Investors can sign up for free and register to meet FDBK via the following link: https://www.investormeetcompany.com/feedback-plc/register-investor

Investors who have already registered on the Investor Meet Company platform to meet the Company will automatically be invited.

--Ends--

Enquiries:

Feedback plc Tom Oakley, CEO Emma Oswick, CFO	+44 (0) 20 3997 7634 IR@fbk.com

Panmure Liberum Limited (NOMAD and Broker) Emma Earl/Mark Rogers (Corporate Finance) Rupert Dearden (Corporate Broking)	+44 (0)20 7886 2500

Walbrook PR Ltd;	Tel: 020 7933 8780 or feedbackplc@walbrookpr.com
Nick Rome/Marcus Ulker	07748 325 236 or 07867 984 082

About Feedback plc

Feedback plc is the strategic partner to unlock productivity in health and care through digital connectivity and asynchronous collaboration. With proven expertise in system integration, we enable teams to work flexibly, share information securely, and deliver care more efficiently.

Bleepa® is an award-winning collaboration platform that improves the quality and productivity of patient pathways enabling health and care organisations to hit targets with their existing clinical workforce. We achieve this by connecting digital infrastructure across systems, enabling asynchronous working, reducing geographic barriers and removing unnecessary appointments.

Bleepa supports the shift from analogue to digital and from hospital to community-based care, by uniting essential data and teams to enhance clinical decision making and enable better coordinated care.

The Company has a number of growth opportunities domestically and internationally across a range of public and private healthcare markets including the NHS. Our highly scalable software-as-a-service (SaaS) based model is expected to provide increasing levels of revenue visibility as the Company grows its customer base.

https://fbk.com

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END